|
|
|
|
LEADER |
04090nma a2200937 u 4500 |
001 |
EB002132278 |
003 |
EBX01000000000000001270335 |
005 |
00000000000000.0 |
007 |
cr||||||||||||||||||||| |
008 |
221110 ||| eng |
020 |
|
|
|a 9783036551036
|
020 |
|
|
|a books978-3-0365-5104-3
|
020 |
|
|
|a 9783036551043
|
100 |
1 |
|
|a Comino, Isabel
|
245 |
0 |
0 |
|a Gluten Related Disorders
|h Elektronische Ressource
|b Coeliac Disease and Beyond
|
260 |
|
|
|b MDPI - Multidisciplinary Digital Publishing Institute
|c 2022
|
300 |
|
|
|a 1 electronic resource (164 p.)
|
653 |
|
|
|a age
|
653 |
|
|
|a flow cytometry
|
653 |
|
|
|a non-dietary therapies
|
653 |
|
|
|a lesion grade
|
653 |
|
|
|a coeliac disease
|
653 |
|
|
|a Bacteroides caccae
|
653 |
|
|
|a relatives
|
653 |
|
|
|a gluten proteins
|
653 |
|
|
|a case management
|
653 |
|
|
|a dietary adherence
|
653 |
|
|
|a gingival bleeding
|
653 |
|
|
|a n/a
|
653 |
|
|
|a gluten excretion urine
|
653 |
|
|
|a symptoms
|
653 |
|
|
|a sex
|
653 |
|
|
|a Saccharomyces cerevisiae
|
653 |
|
|
|a Medicine / bicssc
|
653 |
|
|
|a dietitian
|
653 |
|
|
|a gluten
|
653 |
|
|
|a oral diseases
|
653 |
|
|
|a patients with CD
|
653 |
|
|
|a anemia
|
653 |
|
|
|a immunogenicity
|
653 |
|
|
|a gliadin
|
653 |
|
|
|a sleep-related breathing disorders
|
653 |
|
|
|a vital gluten
|
653 |
|
|
|a data mining gluten free diet
|
653 |
|
|
|a hidden gluten
|
653 |
|
|
|a iron transporter
|
653 |
|
|
|a FODMAP diet
|
653 |
|
|
|a microbiota
|
653 |
|
|
|a oat
|
653 |
|
|
|a non-coeliac gluten sensitivity
|
653 |
|
|
|a tissue transglutaminase-targeted IgA deposits
|
653 |
|
|
|a tissue biomarkers
|
653 |
|
|
|a interceptive orthodontics
|
653 |
|
|
|a celiac disease
|
653 |
|
|
|a tissue transglutaminase autoantibody
|
653 |
|
|
|a functional bowel disease
|
653 |
|
|
|a gluten cross-contaminations
|
653 |
|
|
|a oral prevention
|
653 |
|
|
|a gluten-free diet
|
653 |
|
|
|a gluten-free diet monitoring
|
653 |
|
|
|a gluten immunogenic peptides
|
653 |
|
|
|a rural health services
|
653 |
|
|
|a Pseudomonas fluorescens
|
653 |
|
|
|a enamel defects
|
653 |
|
|
|a intraepithelial lymphocytes TCRγδ+
|
653 |
|
|
|a treatment adherence and compliance
|
653 |
|
|
|a IgA nephropathy
|
653 |
|
|
|a oral health
|
653 |
|
|
|a evidence-based practice
|
700 |
1 |
|
|a Sousa, Carolina
|
700 |
1 |
|
|a Comino, Isabel
|
700 |
1 |
|
|a Sousa, Carolina
|
041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
989 |
|
|
|b DOAB
|a Directory of Open Access Books
|
500 |
|
|
|a Creative Commons (cc), https://creativecommons.org/licenses/by/4.0/
|
024 |
8 |
|
|a 10.3390/books978-3-0365-5104-3
|
856 |
4 |
0 |
|u https://www.mdpi.com/books/pdfview/book/6084
|7 0
|x Verlag
|3 Volltext
|
856 |
4 |
2 |
|u https://directory.doabooks.org/handle/20.500.12854/93188
|z DOAB: description of the publication
|
082 |
0 |
|
|a 610
|
082 |
0 |
|
|a 380
|
520 |
|
|
|a Among gluten-related disorders, coeliac disease (CD) is the best-known one to date, a chronic immune-mediated enteropathy triggered by exposure to gluten in genetically predisposed individuals. It is a common disease, occurring at all ages and characterized by a wide spectrum of clinical manifestations, affecting any organ or tissue. The diagnosis rate of this pathology has increased in the last 10 years, so worldwide epidemiologic data are now available that show that CD is ubiquitous, with a prevalence of 1.4%, higher in female than male individuals. Currently, the only effective treatment for CD is strict and lifelong adherence to a gluten-free diet (GFD). However, CD research is changing rapidly due to the continuous advancing of knowledge. For this reason, the main goal of this Special Issue has been to address the existing knowledge gaps and help advance such important aspects as the pathophysiology, diagnosis, follow-up, and therapeutic options of this pathology. This Special Issue includes 12 peer-reviewed articles reporting on the latest research findings in and evidence related to CD. The published articles cover a range of topics central to CD and GFDs.
|